Company Profiles

driven by the PitchBook Platform

Ora Bio

2005 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Manufacturer of drug for lung cancer. The company develops two products such as the ORA101 for non-small cell lung cancer and ORA102 for age-related macular degeneration.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
P.O. Box 1252
Nazareth Illit 17000
Israel

+972 (0)4 656 4118
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ora Bio’s full profile, request a free trial.

Ora Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 30-May-2006 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Ora Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

You’re viewing 1 of 1 investors.

Ora Bio Executive Team (1)

Name Title Board
Seat
Contact
Info
Josef Israeli Co-Founder & Co-Chief Executive Officer

You’re viewing 1 of 1 executives.

Ora Bio Board Members (1)

Name Representing Role Since Contact
Info
Gary Jacobs Ora Bio Chairman 000 0000

You’re viewing 1 of 1 board members.